Ethylene

Ethylene

SCHEMBL6997790

C=C.CCOC(C)OCC.O=C1CN(CCCN2CCC(C(=O)c3ccc(F)cc3F)CC2)S(=O)(=O)c2ccccc21

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.41
TDP1 Q9NUW8 2/20 0.38
ADRA1D P25100 1/20 0.36
ADRA1A P35348 1/20 0.36
ADRA1B P35368 1/20 0.36
CTDSP1 Q9GZU7 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
HTR2A P28223 3/20 0.35
ALDH1A1 P00352 1/20 0.35
KDM4E B2RXH2 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
HRH3 Q9Y5N1 1/20 0.34
HTR2C P28335 2/20 0.34
DRD2 P14416 1/20 0.34
GRM2 Q14416 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene SCHEMBL6996889 0.81 DRD2 (0.41) HTR2AKDM4ECYP1A2CYP3A4CYP2D6
Ethylene SCHEMBL6990074 0.81 DRD2 (0.41) HTR2AKDM4ECYP1A2CYP3A4CYP2D6
Ethylene SCHEMBL6995999 0.81 DRD2 (0.45) KCNH2TDP1ADRA1AADRA1BHTR2A
Ethylene SCHEMBL6991436 0.80 TDP1 (0.42) TDP1CTDSP1MEN1KMT2ACYP1A2
Ethylene SCHEMBL6995216 0.80 DRD2 (0.51) HTR2AALDH1A1HTR2CDRD2
Ethylene SCHEMBL6994271 0.80 DRD2 (0.49) HTR2AALDH1A1HTR2CDRD2
Ethylene SCHEMBL6996278 0.80 HTR1A (0.46) TDP1ADRA1DADRA1AADRA1BHTR2A
Ethylene SCHEMBL6998096 0.80 ADRA1D (0.38) KCNH2ADRA1DADRA1BHTR2ADRD2
Ethylene SCHEMBL6996783 0.80 HTR2A (0.51) KCNH2HTR2AHTR2CDRD2
Ethylene SCHEMBL6998179 0.79 DRD2 (0.47) KCNH2TDP1ADRA1AADRA1BHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6664251-B2 Serotonin receptor antagonist; treating cardiovascular disorder DAIICHI SUNTORY PHARMA CO., LTD. (JP) 2003-12-16 US disclosed
EP-0686632-B1 BENZOTHIAZINE DERIVATIVE DAIICHI SUNTORY PHARMA CO LTD (JP) 2003-08-06 EP disclosed
US-20030078256-A1 Benzothiazine derivative SUNTORY LIMITED (JP) 2003-04-24 US disclosed
US-6316442-B1 TREATMENT OF HEART DISEASE AND CEREBROVASCULAR DISTURBANCES SUNTORY LIMITED (JP) 2001-11-13 US disclosed
US-6001827-A Benzothiazine derivative SUNTORY LIMITED (JP) 1999-12-14 US disclosed
EP-0686632-A1 BENZOTHIAZINE DERIVATIVE SUNTORY LIMITED (JP) 1995-12-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078256-A1 Benzothiazine derivative TPH2, ADRB2, TPH1 KCNH2 79/4885TDP1 3378/4885ADRA1D 44/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.